China Pharma Holdings (CPHI) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $33.0 million.
- China Pharma Holdings' Accumulated Depreciation & Amortization rose 110.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 110.0%. This contributed to the annual value of $32.1 million for FY2024, which is 560.54% up from last year.
- China Pharma Holdings' Accumulated Depreciation & Amortization amounted to $33.0 million in Q3 2025, which was up 110.0% from $32.6 million recorded in Q2 2025.
- China Pharma Holdings' 5-year Accumulated Depreciation & Amortization high stood at $33.0 million for Q3 2025, and its period low was $26.1 million during Q2 2021.
- In the last 5 years, China Pharma Holdings' Accumulated Depreciation & Amortization had a median value of $29.4 million in 2023 and averaged $29.8 million.
- In the last 5 years, China Pharma Holdings' Accumulated Depreciation & Amortization skyrocketed by 2276.97% in 2021 and then skyrocketed by 68.1% in 2022.
- Quarter analysis of 5 years shows China Pharma Holdings' Accumulated Depreciation & Amortization stood at $28.2 million in 2021, then grew by 0.68% to $28.4 million in 2022, then increased by 7.21% to $30.4 million in 2023, then increased by 5.61% to $32.1 million in 2024, then grew by 2.72% to $33.0 million in 2025.
- Its Accumulated Depreciation & Amortization was $33.0 million in Q3 2025, compared to $32.6 million in Q2 2025 and $32.3 million in Q1 2025.